Terumo Corporation ( OTCPK:TRUMF) Q3 2025 Earnings Conference Call February 13, 2025 3:00 AM ET [Call Starts Abruptly] Thank you for your kind introduction. I’m Hagimoto, Terumo’s CFO. This ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

Shareholder distributions are appropriate. Capital intensity of the industry remains low and gross margins high. In addition, Cochlear enjoys high cash conversion, enabling it to typically pay out 70% ...

Taking prescribed beta blockers during hematopoietic stem cell transplantation may increase mortality risk due to suppression of signals from nerves that promote bone marrow regeneration, according to ...

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

The small-molecule discovery could help in overcoming cell culture bottlenecks such as rapid degradation and high production costs.